Insider Transactions in Q2 2025 at Beam Therapeutics Inc. (BEAM)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price | 
|---|---|---|---|---|---|
| 
           
            Apr 02                          
            2025                          
           
         |           
        Amy Simon Chief Medical Officer | 
           
              SELL
             
            
                Open market or private sale
             
           | 
        Direct | 
           
              20,997
              -24.21%
              
         |   
        
           
              $356,949              
              $17.73 P/Share              
                     
         | 
      
| 
           
            Apr 01                          
            2025                          
           
         |           
        Amy Simon Chief Medical Officer | 
           
              SELL
             
            
                Open market or private sale
             
           | 
        Direct | 
           
              9,566
              -9.93%
              
         |   
        
           
              $172,188              
              $18.35 P/Share              
                     
         | 
      
| 
           
            Apr 01                          
            2025                          
           
         |           
        Bethany J Cavanagh SVP, Finance and Treasurer | 
           
              SELL
             
            
                Open market or private sale
             
           | 
        Direct | 
           
              3,015
              -6.34%
              
         |   
        
           
              $54,270              
              $18.35 P/Share              
                     
         | 
      
| 
           
            Apr 01                          
            2025                          
           
         |           
        Giuseppe Ciaramella President | 
           
              SELL
             
            
                Open market or private sale
             
           | 
        Direct | 
           
              7,434
              -3.76%
              
         |   
        
           
              $133,812              
              $18.35 P/Share              
                     
         | 
      
| 
           
            Apr 01                          
            2025                          
           
         |           
        John M. Evans CEO | 
           
              SELL
             
            
                Open market or private sale
             
           | 
        Direct | 
           
              30,663
              -3.02%
              
         |   
        
           
              $551,934              
              $18.35 P/Share              
                     
         | 
      
| 
           
            Apr 01                          
            2025                          
           
         |           
        Christine Bellon Chief Legal Officer | 
           
              SELL
             
            
                Open market or private sale
             
           | 
        Direct | 
           
              5,674
              -4.61%
              
         |   
        
           
              $102,132              
              $18.35 P/Share              
                     
         |